학술

High blood pressure among children and adolescents with type 1 diabetes mellitus in Uganda: A multicenter cross-sectional study

PLOS ONE
CC BY
이 매체는 공공·자유 라이선스로 본문을 직접 표시합니다.

Figures
Abstract
Background
The coexistence of diabetes mellitus (DM) and hypertension (HTN) worsens the clinical outcomes of children with diabetes concerning both microvascular and macrovascular disease. It increases mortality risk by 5 times, with a higher risk of death in developing countries. Therefore, comprehensive care for patients with diabetes, including hypertension screening, must be provided.
Methods
This multicenter health facility-based cross-sectional study included 150 children and adolescents aged from 6 months to 18 years with type 1 diabetes mellitus (T1DM) who were treated at Jinja Regional Referral Hospital (JRRH), Mbale Regional Referral Hospital (MRRH) and Lira Regional Referral Hospital (LRRH). Interviewer-administered questionnaires were used to obtain data, which were then analyzed according to the study objectives using STATA® version 18. High blood pressure diagnosis was based on blood pressure (BP) above or equal to the 90th percentile for <13 years and either systolic BP ≥ 120 mmHg or Diastolic BP ≥ 80mmhg for 13 years and older for age, sex and height. The prevalence of high BP was determined as a percentage, whereas associated factors were analyzed at both bivariate and multivariable logistic regression. The significance of associations was set at a p-value <0.05 and a 95% confidence interval.
Results
Of the 150 participants, 115 (76.7%) were above 12 years of age, and the median age was 15 years (IQR 13–17). There were more females [81/150 (54%)] than males. The majority were attending school [130/150 (86.7%)], with a few attending boarding school [26/130 (20%)]. Sixty-one participants (40.7%, 95% C.I 33%−49%) had high BP, and 53 (86.9%) of these patients had poor glycemic control. The factors associated with high BP among T1DM participants included having diabetes for 4–8 years (aOR= 2.23 [95% CI: 1.05–4.75]; p = 0.037), and 9–12 years (aOR= 4.545 [95% CI: 1.075–19.221]; p = 0.040) respectively compared to those less than 4 years. Additionally, having Poor glycemic control (HBA1C ≥ 7%) increased odds for high BP by 2.905 [95% CI: 1.149–7.342]; p = 0.024) times compared to their counterparts with good glycemic control.
Citation: Mutisya CM, Nduwimana M, Kajoba D, Ndeezi G (2026) High blood pressure among children and adolescents with type 1 diabetes mellitus in Uganda: A multicenter cross-sectional study. PLoS One 21(11): e0363283. https://doi.org/10.1371/journal.pone.0363283
Editor: Toshiki Maeda, Fukuoka University, JAPAN
Received: June 10, 2026; Accepted: November 5, 2026; Published: November 20, 2026
Copyright: © 2026 Mutisya et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: The dataset used for this study has been submitted along with the manuscript.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Globally, more than 9.5 million people live with type 1 diabetes mellitus (T1DM), and a greater burden is expected to rise in the low- and middle-income countries [1,2]. According to the SEARCH for Diabetes in Youths, the estimated DM incidence is approximately 2.22 cases/1,000 young people with T1DM, accounting for 1.93/1,000 [3]. The International Diabetes Federation (2025) estimates that approximately 1.9 million children and adolescents are living with T1DM globally [2].
The coexistence of diabetes mellitus (DM) and hypertension (HTN) worsens the clinical outcomes of children with diabetes concerning both microvascular and macrovascular disease [4]. It leads to a four-fold increase in cardiovascular disease [5],80% of end-stage renal disease [6] and a fivefold increase in mortality risk due to hypertension-related vascular complications [7].
Diabetes Mellitus has been predominantly regarded as a disease of the Western developed world and thus receives little recognition in low resource countries, leading to low diabetes education, awareness and limited access to innovative treatment like continuous glucose monitoring, insulin pumps among others [8]. There has been for long poor reporting of diabetes in developing countries but there’s current recognition of the rise in incidence of pediatric diabetes in sub-Saharan Africa, including Uganda, but with little documentation and reporting [9].
In Lithuania, T1DM was associated with a 29.8% prevalence of hypertension among children and adolescents, and 24% had at least one microvascular complication [10]. South Africa reported at 48.7% among children and adolescents aged 1–19 years living with T1DM at Tygerberg hospital [11] and 0.1% in Nigerian adolescents 13–19 years with prediabetes [12].
Rwanda, under the International Diabetes Federation’s Life for a Child (LFAC) program, reported a 31.8% prevalence of hypertension among children and adolescents with T1DM, with a 42% increase in burden after 1 year of follow-up to 44.9% [13].
However, the disease burden of HTN and DM is estimated to double by 2025 and 2035, respectively, with DM increasing by 166.9% between 2013 and 2035 [14,15]. Uganda is currently projected to have more than 2300 children and adolescents living with T1DM [6]. The estimated national T1DM prevalence is 1.4% of all DM cases [16], with a 24.3% burden of hypertension among the population with diabetes. In southwestern Uganda, it has been reported that 45% of people with diabetes visit Kitagata District Hospital [17,18]. However, all these studies reported in Uganda are in adults, and studies in children and adolescents are limited. Therefore, the researchers sought to determine the prevalence and factors associated with high blood pressure among study participants in Uganda.
Materials and methods
Study area
This was a multicenter study conducted at Jinja, Lira and Mbale Regional referral hospitals. All the 3 facilities are public health facilities with a well-established diabetes clinic forming part of the type 1 Diabetes mellitus program/changing diabetes initiative with support from Novo Nordisk. Jinja Regional Referral Hospital (JRRH) also serves as a teaching hospital for Kampala International University for both undergraduates and postgraduate medical students. It is a 500-bed capacity serving the districts of Bugiri, Iganga, Jinja, Kaliro, Luuka, Mayunge, Namayingo, Kayunga and parts of Buikwe. It is located approximately 82 km east of Kampala, Uganda’s capital. It has a diabetic clinic running on a weekly basis with 122 registered clients, 52 of whom are 18 years and younger.
Lira Regional Referral Hospital (LRRH) is a government-owned specialized hospital that serves the northern region and covers the districts of Amolatar, Apac, Dokholo, Lira, Kole and Oyam. It also serves as a teaching hospital for Kampala International University students, both undergraduate and postgraduate medical students. It is a 400-bed capacity hospital located approximately 342 km north of Kampala city. It has a well-established diabetic clinic running every Thursday, with a total of 197 registered clients, of whom 84 are 18 years and younger.
The Mbale regional referral hospital (MRRH) is a 415-bed capacity hospital that serves the eastern Uganda districts of Budaka, Bukwa, Mbale, Pallisa, Sironko, Bulambuli, Bududa and Tororo. It has a well-established diabetic clinic running on a weekly basis with over 180 registered clients, 56 of whom are 18 years and younger.
Services offered in these clinics include health education, nutritional support, clinical reviews, laboratory investigations, such as random blood sugar, urinalysis and glycated hemoglobin (HbA1C) and the provision of free antidiabetic medications (insulin) on routine weekly clinics.
Research design and methodology
The sample size for the associated factors was determined using the Open Epi calculator for two proportions, considering a 95% confidence interval and a power of 80%. Based on a study that found that obesity was a risk factor for HTN, in that it increased the odds of hypertension among diabetic patients by 2.6 times compared with those with a normal weight [20]. Considering Kelsey’s formula, a sample size of 144 participants was required. In the end, the larger sample size of 144 was used as the minimal sample size for the study, to which were added 6 participants (4%) to cater for withdrawals.
Procedures
Ethical approval
Data analysis
Descriptive statistics using frequencies, percentages, median and interquartile range were used to analyze the independent and dependent variables using STATA version 18. The associations between independent and dependent variables were determined via binary logistic regression for both bivariate and multivariable analyses, with the P value significance set at <0.05. Variables with a P-value of less than 0.2 at bivariate level and a significant 95% confidence interval, were subjected to multivariable logistic regression to establish association between the variables and high blood pressure among children and adolescents living with T1DM.
Operational terms
- High blood pressure: systolic and or diastolic pressure above or equal to the 90th percentile for age, sex and height for children younger than 13 years and either systolic BP ≥ 120 mmHg or Diastolic BP ≥ 80mmhg for age, sex and height for those above 13 years [22].
- Elevated blood pressure: systolic and or diastolic blood pressure at or above the 90th percentile to less than 95th percentile for age sex and height for children young than 13 years and BP 120–129/ < 80 mmhg.
- Hypertension: blood pressure at or above the 95th percentile for age sex and height for those aged less than 13 years and BP ≥ 130/80mmhg for those 13 years and above.
- Hypertension stage 1: blood pressure at or above the 95th percentile but less than 95th percentile + 12 mmhg for age sex and height for those aged less than 13 years and BP 130–139/80–89mmhg for those 13 years and above.
- Hypertension stage 2: blood pressure at or above the 95th percentile + 12 mmhg for age sex and height for those aged less than 13 years and BP ≥ 140/90mmhg for those 13 years and above.
- Poor glycemic control: having HbA1c greater than or equal to 7%.
Results
Study participants
A total of 164 children and adolescents living with T1DM attended the various clinics during the study period of which 150 enrolled in the study. There were 41 participants from JRRH, 65 from LRRH and 44 from MRRH, between October and December 2023 (Fig 1).
Baseline characteristics
The median age of the study participants was 15 (IQR 13–17) years, and the majority were females 81 (54%). Over two-thirds of the participants had at most primary-level education, 103 (68.7%), and the majority of caretakers were aged 31–50 years (72.0%). This is shown in Table 1 below.
Prevalence of high blood pressure
There was a 40.7% (C.I 33%−49%) burden of high blood pressure among the children and adolescents living with T1DM in selected study sites. Among the participants with high blood pressure, 22 were from Mbale RRH, followed by Jinja RRH, 20 and 19 from Lira RRH, showing the high blood pressure site distribution among the study participants(Fig 2).
Among the 61 patients with high blood pressure, 32 (52.5%) had elevated blood pressure, whereas the rest had hypertension range blood pressure with Stage 1 Hypertension affecting 32.8% [20] of the study participants, as shown in Table 2 below.
Factors associated with high blood pressure
In the bivariate analysis, the factors associated with high BP were family history of hypertension (cOR 2.002 [95% C.I 1.025–3.912]; p = 0.042), duration of disease of 4–8 years (cOR 2.562 [95% CI 1.233–5.321]; p = 0.012), and 9–12 years duration (cOR 5.977 [95% CI 1.478–24.171]; p = 0.012) and poor glycemic control (cOR 2.885 [95% CI 1.209–6.886]; p = 0.014). The results are shown in Tables 3, 4, 5. These were further subjected to multivariable analysis to establish a relationship with high blood pressure and to control for confounding variables.
The statistically significant factors at the multivariable level analysis associated with high blood pressure include duration of diabetes and poor glycemic control. Living with type 1 diabetes for 4–8 years increased the odds of having high blood pressure by 2.233 (p = 0.037) and those 9–12 years by 4.545 (p = 0.040) times compared to those less than 4 years. Poor glycemic control over 3 months increased the odds of high blood pressure by 2.905 (p = 0.024) compared with those with good glycemic control. The overall model fit was significant with an omnibus test of model coefficient p-value of 0.001(X2 = 19.536, df = 4) and Hosmer- Lemeshow test p-value of 0.867(X2 = 1.867, df = 5) indicating absence of evidence for poor fit. Age had no meaningful collinearity effect with duration of disease and adding it in the model didn’t improve the overall model. There was no missing data for the variables in multivariable model, all the 150 participants were included in the adjusted analysis. This is shown in Table 6 below.
Discussion
The study aimed to determine the prevalence of high blood pressure among children and adolescents living with T1DM in 3 rural tertiary hospitals in Uganda and to describe the factors associated. This was a multicenter cross-sectional enrolling a total of 150 children and adolescents into the study. The study found a 40.7% prevalence of high blood pressure among study participants and the factors associated with increased odds of high blood pressure included prolonged duration of T1DM (≥4 years) and poor glucose control (HbA1C ≥ 7%).
The high burden of high blood pressure among the study participants could be attributed to hyperglycemia and increased free fatty acids associated with T1DM, which leads to oxidative stress by increasing the production of endothelin-1 and angiotensin II, which in turn leads to elevated blood pressure [23]. Worth noting, is 115 (76.6%) of the study participants had poor glucose control while 55 (36.6%) had hyperglycemia. Additionally, it could be a result of hyperglycemia induced endothelia and vascular dysfunction as a result of consumption and decreased bioavailability of nitric oxide, thereby leading to endothelial dysfunction, vasoconstriction, and increased peripheral vascular resistance [24]. This observed high blood pressure prevalence can also be attributed to the fact that a wide age range was included, of 6 months −18 years and high blood pressure (elevated and hypertension BP ranges) was considered rather than hypertension alone.
The study prevalence is higher than the 36.1% and 19.4% reported in Lithuania and Australia, respectively, among T1DM patients less than 18 years of age [7,10]. The difference could be attributed to the difference in inclusion criteria, where James and colleagues enrolled only adolescents aged 16–25 years, whereas the current study enrolled both children and adolescents. Additionally, the current study considered high blood pressure rather than hypertension alone, as in the observed studies. The study recognizes that the high blood pressure could be overestimated given that a single clinic visit measurement was based on to make the diagnosis rather than the at least 3 separate clinic visits recommended [25–27]. However, the study findings represent a growing burden of high blood pressure among children and adolescents with T1DM. This is magnified by the 4-fold increase in cardiovascular disease among T1DM with high blood pressure [5,28]. This makes vigilant screening and prompt initiation of treatment for high blood pressure a key intervention strategy among T1DM patients [29,30].
There were higher odds for having high BP among children and adolescents living with T1DM for more than 4 years. There was a 2.233 increased odds for children and adolescents living with T1DM for 4–8 years and 4.545 higher odds for those living with T1DM for 9–12 years compared to those with less than 4 years with T1DM. Prior studies propose high blood pressure to be due to vascular damage that is attributable to a longer period of exposure to high levels of inflammatory cytokines seen during hyperglycemia than during a shorter duration of diabetes, which leads to an autonomous imbalance and blood vessel stiffening, resulting in hypertension [23,31]. This agrees with the findings of a longitudinal study in East London, where after 4 years of follow-up of T1DM patients, the burden of elevated blood pressure increased from 20.5% to 31.7% [32]. In Rwanda, it increased from 31.8% at baseline to 44.9% and 40.3% at the 1- and 2-year follow-up periods, respectively [13].
Additionally, the observed high BP could plausibly be attributed to an underlying diabetic nephropathy for which High BP acts as both a clinical feature and risk factor [33]. This follows the ongoing persistent albuminuria and decreasing glomerular filtration rate (GFR), which proceed to chronic kidney disease (CKD) and end-stage renal disease [34]. A study in Egypt among children and adolescents with T1DM found diabetic nephropathy in 13% with a greater association with participants with higher HbA1c and duration of diabetes (>5 years) [35]. In our current study, 115 of our study participants had poor glycemic control with HbA1c ≥ 7%. Additionally, 56 of participants in the current study have had T1DM for more than 4 years. This serves as a plausible explanation since the study was unable to rule out kidney disease among the study participants and relied entirely on history alone.
Mariye and colleagues, in their study in Tigray, Ethiopia, reported an 8.52-fold increased risk for hypertension with a long duration (> 6 years) since DM diagnosis compared with a short duration (less than 1 year) [31]. In southern Ethiopia, the hypertension risk was 7 times greater when the duration of DM was longer than 5 years since diagnosis [20]. In the current study over 52.5% of the study participants with high blood pressure had been living with T1DM for more than 4 years. This strongly calls into effect the ISPAD recommendation of blood pressure screening of all diabetic patients at every visit following the diagnosis of T1DM, as early diagnosis and intervention are the only remedies for worsening microvascular damage [36]. Additionally, the longer the duration of the disease is, the greater the burden of masked hypertension among patients with T1DM [23]. Unfortunately, ambulatory blood pressure monitoring was not done thus unable to rule out masked hypertension.
Compared with good glycemic control, poor glycemic control over 3 months was associated with roughly three times higher odds of high BP among the study participants. This is because high glycated hemoglobin reflects poor glucose control with variable glycemic levels, yet hyperglycemia increases sympathetic activity, activates the renin‒angiotensin system and alters vascular wall function over time, leading to increased vascular resistance in peripheral vessels and thus the development of high blood pressure [37]. Additionally, poor glycemic control is associated with a high level of dyslipidemia, which is associated with the early development of cardiac and vascular abnormalities through the process of atherosclerosis and thus hypertension development [10].
In 2016, De Oliveira and colleagues reported a 1.73 mmHg increase in diastolic blood pressure among DM type 1 patients for every 1% increase in HbA1c. This increase is detrimental among T1DM, as it can increase the risk of stroke by 14–17% and coronary artery disease by 6–9% [38]. Additionally, higher HbA1c is associated with a 1.07 increased odds for having 24 hour diastolic blood pressure rise and increase in HbA1C is highly associated with rise in diastolic blood pressure and heart rate among children with T1DM [39,40].
The key study findings emphasize the critical need for structured blood pressure surveillance in pediatric T1DM care. Rather than delaying screening until long-term microvascular complications manifest, routine BP monitoring should begin at diagnosis and intensify alongside rising HbA1c levels or advancing disease duration to enable timely risk stratification and preventive intervention. However, because of our cross-sectional design, these associations cannot establish causality.
Study strength
This study was a multicenter cross-sectional study enrolling a total of 150 participants already diagnosed and under care for T1DM across 3 rural tertiary institutions in Uganda, thus reflects a wider population. To the author’s knowledge, it’s the first study in Uganda on high blood pressure in T1DM in children and adolescents, as most studies are in adults.
Limitations
The study was not able to rule out kidney diseases among the study participants, which could affect the observed findings. However, the researchers relied on the known history of kidney diseases to rule out the diseases. Furthermore, as this was a cross- sectional study, and high blood pressure was diagnosed based on a single clinic visit rather than at least 3 separate clinic visit scheduled at a minimum of 2 weeks interval [25]. Because BP fluctuates in children due to anxiety, environment and this risks over estimation of the BP [25,26]. To mitigate this risk and improve diagnostic accuracy, the present study utilized multiple BP measurements taken during a single visit.
Additionally, Ambulatory blood pressure monitoring was not performed, making it impossible to rule out white coat syndrome and masked hypertension. Finally, given the cross-sectional study design, it’s impossible to infer causality; however, this doesn’t preclude the observed association, and a longitudinal study is recommended to establish causality.
Conclusion and recommendations
There was a high prevalence of high blood pressure among T1DM participants, with 4 out of 10 individuals affected. The factors significantly associated with high blood pressure among the T1DM participants were duration of disease since diagnosis of more than 4 years and poor glycemic control. Therefore, there is a strong need to enforce routine blood pressure screening among T1DM patients at every routine visit to achieve early diagnosis and intervention in patients with elevated blood pressure.
References
- 1.
World Health Organisation. Global report on diabetes. Geneva: World Health Organisation; 2016.
- 2.
International Diabetes Federation. IDF diabetes atlas. 11 ed. International Diabetes Federation; 2025.
- 3. Pettitt DJ, Talton J, Dabelea D, Divers J, Imperatore G, Lawrence JM, et al. Prevalence of diabetes in U.S. youth in 2009: The SEARCH for diabetes in youth study. Diabetes Care. 2014;37(2):402–8. pmid:24041677
- 4. Tsimihodimos V, Gonzalez-Villalpando C, Meigs JB, Ferrannini E. Hypertension and diabetes mellitus: Coprediction and time trajectories. Hypertension. 2018;71(3):422–8. pmid:29335249
- 5. Lastra G, Syed S, Kurukulasuriya LR, Manrique C, Sowers JR. Type 2 diabetes mellitus and hypertension: An update. Endocrinol Metab Clin North Am. 2014;43(1):103–22. pmid:24582094
- 6.
International Diabetes Federation. IDF diabetes atlas. 10th ed. Brussels: International Diabetes Federation; 2019.
- 7. James S, Perry L, Lowe J, Harris M, Colman PG, Craig ME, et al. Blood pressure in adolescents and young adults with type 1 diabetes: data from the Australasian Diabetes Data Network registry. Acta Diabetol. 2023;60(6):797–803. pmid:36920547
- 8.
Saiyed M, Hasnani D, Alonso GT, Richmond E, Besançon S, Cotterill A, et al. Worldwide differences in childhood type 1 diabetes: The SWEET experience. 2021; 207–14.
- 9.
Zhang C, Luo X. The increase in diabetes in children from underdeveloped countries. 2024;0.
- 10. Stankute I, Dobrovolskiene R, Danyte E, Razanskaite-Virbickiene D, Jasinskiene E, Mockeviciene G, et al. Factors affecting cardiovascular risk in children, adolescents, and young adults with type 1 diabetes. J Diabetes Res. 2019;2019:9134280. pmid:31223626
- 11. Dookhony LN, Lombard CJ, Zöllner EW. Children and adolescents with diabetes at Tygerberg Hospital – at risk of cardiovascular complications?. South Afr J Child Heal. 2022;16(4):206–9.
- 12. Okpebholo EG, Oludahunsi OF, Ijarotimi OS. Early onset of hypertension and diabetes: prevalence and risk factors among school going adolescents in federal capital territory, North Central Nigeria. Int J Res Innov Appl Sci. 2025;X(1):279–91.
- 13. Marshall SL, Edidin DV, Arena VC, Becker DJ, Bunker CH, Gishoma C, et al. Glucose control in Rwandan youth with type 1 diabetes following establishment of systematic, HbA1c based, care and education. Diabetes Res Clin Pract. 2015;107(1):113–22. pmid:25458328
- 14. Chang H, Hawley NL, Kalyesubula R, Siddharthan T, Checkley W, Knauf F, et al. Challenges to hypertension and diabetes management in rural Uganda: A qualitative study with patients, village health team members, and health care professionals. Int J Equity Health. 2019;18(1):38. pmid:30819193
- 15. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49. pmid:24630390
- 16. Bahendeka S, Wesonga R, Mutungi G, Muwonge J, Neema S, Guwatudde D. Prevalence and correlates of diabetes mellitus in Uganda: A population-based national survey. Trop Med Int Health. 2016;21(3):405–16. pmid:26729021
- 17. Chiwanga FS, Njelekela MA, Diamond MB, Bajunirwe F, Guwatudde D, Nankya-Mutyoba J, et al. Urban and rural prevalence of diabetes and pre-diabetes and risk factors associated with diabetes in Tanzania and Uganda. Glob Health Action. 2016;9:31440. pmid:27221531
- 18. Dickson K. Prevalence of diabetes and its associated risk factors in south-western Uganda. Am J Diabetes Med. 2016;24(1):15–7.
- 19. Krejcie RV, Morgan DW. Determining sample size for research activities. Edu Psych Measure. 1970;30(3):607–10.
- 20. Anjajo EA, Workie SB, Tema ZG, Woldegeorgis BZ, Bogino EA. Determinants of hypertension among diabetic patients in southern Ethiopia: a case-control study. BMC Cardiovasc Disord. 2023;23(1):233. pmid:37138213
- 21. Álvarez J, Aguilar F, Lurbe E. Blood pressure measurement in children and adolescents: Key element in the evaluation of arterial hypertension. An Pediatr (Engl Ed). 2022;96(6):536.e1-536.e7. pmid:35659490
- 22. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics. 2017;140(3):e20171904. pmid:28827377
- 23. Homhuan W, Poomthavorn P, Paksi W, Khlairit P, Nongnuch A, Pirojsakul K. Masked hypertension and its associations with glycemic variability metrics in children and adolescents with type 1 diabetes. Pediatr Nephrol. 2021;36(2):379–86.
- 24. Downie ML, Ulrich E, Noone DG. An update on hypertension in children with type 1 diabetes. Can J Diabetes. 2018;:1–28.
- 25. Zheng L, Xiang W, Zheng R, Min X, Dai L, Chen J, et al. Prevalence of and factors influencing elevated blood pressure among Chinese adolescents: a cross-sectional study. BMJ Open. 2025;15(9):e099250. pmid:40983569
- 26. Sun J, Steffen LM, Ma C, Liang Y, Xi B. Definition of pediatric hypertension: Are blood pressure measurements on three separate occasions necessary?. Hypertens Res. 2017;40(5):496–503. pmid:28077857
- 27. Lurbe E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, Erdine S, Hirth A, et al. 2016 European society of hypertension guidelines for the management of high blood pressure in children and adolescents. J Hypertens. 2016;34(10):1887–920. pmid:27467768
- 28. Sowers JR, Whaley-Connell A, Hayden MR. The Role of Overweight and Obesity in the Cardiorenal Syndrome. Cardiorenal Med. 2011;1(1):5–12. pmid:22258461
- 29.
American Diabetes Association. Children and adolescents: Standards of medical care in diabetes d 2019. Diabetes Care. 2019;42:148–64.
- 30. Zeitler P, Arslanian S, Fu J, Hamiel TOP, Tandon N, Urakami T. ISPAD clinical practice consensus guidelines 2018: Type 2 diabetes mellitus in youth. Pediatr Diabetes. 2018;19(Suppl. 27):28–46.
- 31.
Mariye T, Girmay A, Tasew H, Teklay G, Ayele E, Gerensea H. Determinants of hypertension among diabetic patients in public hospitals of the central zone, Tigray, Ethiopia 2018: Unmatched case-control study. 2019;8688:1–12.
- 32. Jones S, Khanolkar AR, Gevers E, Stephenson T, Amin R. Cardiovascular risk factors from diagnosis in children with type 1 diabetes mellitus: A longitudinal cohort study. BMJ Open Diabetes Res Care. 2019;7(1):e000625. pmid:31641519
- 33. Mamilly L, Mastrandrea LD, Mosquera Vasquez C, Klamer B, Kallash M, Aldughiem A. Evidence of early diabetic nephropathy in pediatric type 1 diabetes. Front Endocrinol (Lausanne). 2021;12:669954. pmid:33995287
- 34. Ratan Y, Rajput A, Pareek A, Pareek A, Singh G. Comprehending the role of metabolic and hemodynamic factors alongside different signaling pathways in the pathogenesis of diabetic nephropathy. Int J Mol Sci. 2025;26(7):3330. pmid:40244213
- 35. Darwish RM, Ghanem AI, Altohamy JI, Khalifa DM. Prevalence of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: A. J Med Sci Res. 2026;9(2).
- 36. Limbert C, Tinti D, Malik F, Kosteria I, Messer L, Jalaludin YM, et al. ISPAD clinical practice consensus guidelines 2022: The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pediatric Diabetes. 2022;23:1243–69.
- 37. Akram NN, Abdullah WH, Ibrahim BA. Factors contribute to elevated blood pressure values in children with type 1 diabetes mellitus. Medical J Babylon. 2022;19(2):126–8.
- 38. de Oliveira S, da Cunha Nascimento D, Tibana RA, de Oliveira SL, de Sousa Neto IV, Falleiros RKMM, et al. Elevated glycated hemoglobin levels impair blood pressure in children and adolescents with type 1 diabetes mellitus. Diabetol Metab Syndr. 2016;8:4. pmid:26759608
- 39. Torchinsky MY, Gomez R, Rao J, Vargas A, Mercante DE, Chalew SA. Poor glycemic control is associated with increased diastolic blood pressure and heart rate in children with Type 1 diabetes. J Diabetes Complications. 2004;18(4):220–3. pmid:15207840
- 40. Stępniewska A, Szczudlik E, Drożdż D, Nazim J, Starzyk J, Januś D, et al. Diastolic blood pressure abnormalities and their relationship with glycemic control in pediatric Type 1 diabetes. J Clin Med. 2025;14(13):4704. pmid:40649077

관련 뉴스